Literature DB >> 7704921

Global data on blindness.

B Thylefors1, A D Négrel, R Pararajasegaram, K Y Dadzie.   

Abstract

Globally, it is estimated that there are 38 million persons who are blind. Moreover, a further 110 million people have low vision and are at great risk of becoming blind. The main causes of blindness and low vision are cataract, trachoma, glaucoma, onchocerciasis, and xerophthalmia; however, insufficient data on blindness from causes such as diabetic retinopathy and age-related macular degeneration preclude specific estimations of their global prevalence. The age-specific prevalences of the major causes of blindness that are related to age indicate that the trend will be for an increase in such blindness over the decades to come, unless energetic efforts are made to tackle these problems. More data collected through standardized methodologies, using internationally accepted (ICD-10) definitions, are needed. Data on the incidence of blindness due to common causes would be useful for calculating future trends more precisely.

Entities:  

Mesh:

Year:  1995        PMID: 7704921      PMCID: PMC2486591     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  4 in total

1.  [Epidemiological surveillance of trachoma: evaluation and perspective].

Authors:  B Thylefors; A D Négrel; R Pararajasegaram
Journal:  Rev Int Trach Pathol Ocul Trop Subtrop Sante Publique       Date:  1992

2.  A simplified methodology for the assessment of blindness and its main causes.

Authors:  B Thylefors
Journal:  World Health Stat Q       Date:  1987

3.  The global impact of glaucoma.

Authors:  B Thylefors; A D Négrel
Journal:  Bull World Health Organ       Date:  1994       Impact factor: 9.408

4.  Ocular trauma.

Authors:  J D Anderson; A Foster
Journal:  Trop Doct       Date:  1989-01       Impact factor: 0.731

  4 in total
  283 in total

1.  The Age-Related Eye Disease Study (AREDS): design implications. AREDS report no. 1.

Authors: 
Journal:  Control Clin Trials       Date:  1999-12

2.  Can we eliminate trachoma?

Authors:  T Lietman; A Fry
Journal:  Br J Ophthalmol       Date:  2001-04       Impact factor: 4.638

3.  Protection against UVB inactivation (in vitro) of rat lens enzymes by natural antioxidants.

Authors:  G B Reddy; K S Bhat
Journal:  Mol Cell Biochem       Date:  1999-04       Impact factor: 3.396

4.  Identification of an antigen localized to an apparent septum within dividing chlamydiae.

Authors:  W J Brown; D D Rockey
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

Review 5.  Eradication of trachoma worldwide.

Authors:  D Mabey; R Bailey
Journal:  Br J Ophthalmol       Date:  1999-11       Impact factor: 4.638

6.  Trachoma.

Authors:  D Mabey; N Fraser-Hurt
Journal:  BMJ       Date:  2001-07-28

Review 7.  Socioeconomic status and blindness.

Authors:  R Dandona; L Dandona
Journal:  Br J Ophthalmol       Date:  2001-12       Impact factor: 4.638

Review 8.  Blindness in the eastern Mediterranean countries.

Authors:  K F Tabbara
Journal:  Br J Ophthalmol       Date:  2001-07       Impact factor: 4.638

9.  Social economic development in the prevention of global blindness.

Authors:  V H Ho; I R Schwab
Journal:  Br J Ophthalmol       Date:  2001-06       Impact factor: 4.638

Review 10.  Immunity to murine chlamydial genital infection.

Authors:  Richard P Morrison; Harlan D Caldwell
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.